Company: ABUS
Filing Date: 2025-08-06
Form Type: 8-K
Source: 0001171843-25-005076
Chunk: 2

Company: Arbutus Biopharma Corp
Filing Date: 2025-08-06
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01. Other Events.

On August 6, 2025, the Company issued a press release with updates to its ongoing patent infringement litigations against Moderna and Pfizer/BioNTech. In the U. S. litigation against Moderna, Inc. and a Moderna affiliate (collectively, “ Moderna”), the U. S. District Court for the District of Delaware issued a new scheduling order in June 2025 providing for the summary judgment phase of the case to begin in July 2025 and for a jury trial to be held in March 2026. Additionally, in July 2025, the case was reassigned to a different judge in the same court. In the five international lawsuits filed against Moderna and/or its affiliates in March 2025, the first major hearings are expected in the first half of calendar year 2026. In the litigation against Pfizer Inc. and BioNTech SE, the Company noted that the U. S. District Court for the District of New Jersey that is presiding over the case has not provided guidance for the timing of its ruling in the claim construction hearing that occurred in December 2024, but such ruling could potentially come in 2025.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit Number      Description                                                   
            99.1      Press release dated August 6, 2025                            
 ────────────────────────────────────────────────────────────────────────────────────
             104      Cover page interactive data file (formatted as inline XBRL).